⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

April 15, 2024

Supplementary Figure S3 from Paclitaxel and Carboplatin in Combination with Low-intensity Pulsed Ultrasound for Glioblastoma

Karl J. Habashy Crismita Dmello Li Chen Víctor A. Arrieta Kwang‐Soo Kim Andrew Gould Mark W. Youngblood Guillaume Bouchoux Kirsten B. Burdett Hui Zhang Michael Canney Roger Stupp Adam M. Sonabend

View Full Paper

Ask AI

Bookmark

Share

Abstract

Supplementary Figure 3. Paclitaxel and carboplatin exhibit synergy in vitro. (A) Dose-response matrices illustrating the Loewe synergy score calculated for 11 glioma cell lines at clinically relevant PTX and CBDCA concentrations. (B) Bar charts showing the viability of cell lines treated with PTX, CBDCA, or a combination of both drugs at concentration that showed the highest synergy.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Habashy et al. (2024) studied this question.

synapsesocial.com/papers/68e6f2aeb6db64358766d839 https://doi.org/10.1158/1078-0432.25603401

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure S3 from Paclitaxel and Carboplatin in Combination with Low-intensity Pulsed Ultrasound for Glioblastoma2024
2Supplementary Figure S2 from Paclitaxel and Carboplatin in Combination with Low-intensity Pulsed Ultrasound for Glioblastoma2024
3Supplementary Figure S2 from Paclitaxel and Carboplatin in Combination with Low-intensity Pulsed Ultrasound for Glioblastoma2024
4Supplementary Figure S4 from Paclitaxel and Carboplatin in Combination with Low-intensity Pulsed Ultrasound for Glioblastoma2024
5Supplementary Figure S4 from Paclitaxel and Carboplatin in Combination with Low-intensity Pulsed Ultrasound for Glioblastoma2024